Literature DB >> 20097272

Interleukin-18 promoter polymorphisms and risk of ischemic stroke.

Na Zhang1, Jin-Tai Yu, Nan-Nan Yu, Rui-Chun Lu, Teng Ma, Nai-Dong Wang, Dan Miao, Jing-Hui Song, Lan Tan.   

Abstract

Ischemic stroke (IS) is a major cause of morbidity and mortality around the world. Interleukin-18 (IL-18) plays an important role in the pathogenesis of IS and IL-18 promoter polymorphisms have been shown to be associated with levels of expression of IL-18. We investigated the association of two functional polymorphisms in IL-18 promoter, -607C/A (rs1946518) and -137G/C (rs187238), with the risk of ischemic stroke in a Han Chinese population of 423 patients and 384 healthy controls matched for sex and age. The results revealed that the -607C allele was associated with an increased risk of IS with an odds ratios (OR) of 1.358 (P = 0.002, power = 100%) and the presence of the -137G allele was correlated with increased the risk of IS in the subtype of patients with large artery atherosclerosis (LAA) (OR = 1.583, P = 0.02, power = 94%). Patients with the -607C/-137G haplotype also had significantly increased risk of IS compared to controls (OR = 1.341, P = 0.005, power = 100%). Our findings suggest that these functional polymorphisms in the IL-18 promoter are involved in development of IS in the Han Chinese population. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097272     DOI: 10.1016/j.brainresbull.2010.01.008

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  9 in total

1.  Increased IL18 mRNA levels in peripheral artery disease and its association with triglyceride and LDL cholesterol levels: a pilot study.

Authors:  Serkan Burc Deser; Burcu Bayoglu; Kazım Besirli; Mujgan Cengiz; Berk Arapi; Yerik Junusbekov; Ahmet Dirican; Caner Arslan
Journal:  Heart Vessels       Date:  2015-10-05       Impact factor: 2.037

2.  Association between interleukin-18 promoter variants and tacrolimus pharmacokinetics in Chinese renal transplant patients.

Authors:  Jiazhen Xing; Xiaoqing Zhang; Junwei Fan; Bin Shen; Tongyi Men; Jianning Wang
Journal:  Eur J Clin Pharmacol       Date:  2014-12-10       Impact factor: 2.953

3.  Investigation on the IL-18 -607A/C and -137C/G on the susceptibility of ischemic stroke.

Authors:  Jin-He Shi; Li-Dan Niu; Xi-Yan Chen; Jing-Yu Hou; Ping Yang; Guang-Peng Li
Journal:  Pak J Med Sci       Date:  2015 Jan-Feb       Impact factor: 1.088

4.  Interleukin-18 gene promoter 607A polymorphism, but not 137C polymorphism, is a protective factor for ischemic stroke in the Chinese population: A meta-analysis.

Authors:  Ming-Jie Zhang; Yi Zhou; Xu Wang; Xue Chen; Yan Pi; Lu Guo; Chang-Yue Gao; Jing-Cheng Li; Li-Li Zhang
Journal:  Meta Gene       Date:  2016-06-29

5.  Correlation between interleukin-18 promoter -607C/A polymorphism and susceptibility to ischemic stroke.

Authors:  Jian-xia Lu; Zhong-qian Lu; Shao-lan Zhang; Juan Zhi; Zheng-ping Chen; Wan-xiang Wang
Journal:  Braz J Med Biol Res       Date:  2013-05-24       Impact factor: 2.590

6.  Ischemic stroke susceptibility gene in a Northern Han Chinese population.

Authors:  Haiping Wang; Shujuan Shi; Wenjing Yan; Yan Song; Jingjing Zhan; Chen Zhang; Haiji Wang
Journal:  Neural Regen Res       Date:  2013-07-15       Impact factor: 5.135

7.  Association between genetic polymorphisms of interleukins and cerebral infarction risk: a meta-analysis.

Authors:  Jiantao Wang; Niannian Fan; Yili Deng; Jie Zhu; Jing Mei; Yao Chen; Heng Yang
Journal:  Biosci Rep       Date:  2016-11-03       Impact factor: 3.840

8.  Increased Expression of Interleukin-18 mRNA is Associated with Carotid Artery Stenosis

Authors:  Berk Arapi; Burcu Bayoğlu; Müjgan Cengiz; Ahmet Dirican; Serkan Burç Deser; Yerik Junusbekov; Caner Arslan
Journal:  Balkan Med J       Date:  2018-02-27       Impact factor: 2.021

9.  Targeting Oxidative Stress and Inflammation to Prevent Ischemia-Reperfusion Injury.

Authors:  Liquan Wu; Xiaoxing Xiong; Xiaomin Wu; Yingze Ye; Zhihong Jian; Zeng Zhi; Lijuan Gu
Journal:  Front Mol Neurosci       Date:  2020-03-05       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.